INVO Fertility (IVF) Competitors $1.75 +0.03 (+1.74%) As of 08/14/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock IVF vs. DYNT, TTOO, IONM, GMVDF, AFIB, NMRD, UTRS, MOTS, BVS, and CATXShould you be buying INVO Fertility stock or one of its competitors? The main competitors of INVO Fertility include Dynatronics (DYNT), T2 Biosystems (TTOO), Assure (IONM), G Medical Innovations (GMVDF), Acutus Medical (AFIB), Nemaura Medical (NMRD), Minerva Surgical (UTRS), Motus GI (MOTS), Bioventus (BVS), and Perspective Therapeutics (CATX). These companies are all part of the "surgical & medical instruments" industry. INVO Fertility vs. Its Competitors Dynatronics T2 Biosystems Assure G Medical Innovations Acutus Medical Nemaura Medical Minerva Surgical Motus GI Bioventus Perspective Therapeutics INVO Fertility (NASDAQ:IVF) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Do institutionals & insiders have more ownership in IVF or DYNT? 12.0% of INVO Fertility shares are held by institutional investors. Comparatively, 4.2% of Dynatronics shares are held by institutional investors. 0.6% of INVO Fertility shares are held by company insiders. Comparatively, 8.0% of Dynatronics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is IVF or DYNT more profitable? Dynatronics has a net margin of -8.35% compared to INVO Fertility's net margin of -377.73%. INVO Fertility's return on equity of 0.00% beat Dynatronics' return on equity.Company Net Margins Return on Equity Return on Assets INVO Fertility-377.73% N/A -88.18% Dynatronics -8.35%-41.81%-9.56% Which has preferable earnings & valuation, IVF or DYNT? Dynatronics has higher revenue and earnings than INVO Fertility. Dynatronics is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioINVO Fertility$6.53M0.19-$9.10M-$102.18-0.02Dynatronics$33.60M0.04-$2.70M-$0.78-0.12 Which has more volatility and risk, IVF or DYNT? INVO Fertility has a beta of 1.99, indicating that its share price is 99% more volatile than the S&P 500. Comparatively, Dynatronics has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500. Does the media refer more to IVF or DYNT? In the previous week, INVO Fertility had 4 more articles in the media than Dynatronics. MarketBeat recorded 4 mentions for INVO Fertility and 0 mentions for Dynatronics. INVO Fertility's average media sentiment score of 0.93 beat Dynatronics' score of 0.00 indicating that INVO Fertility is being referred to more favorably in the media. Company Overall Sentiment INVO Fertility Positive Dynatronics Neutral SummaryINVO Fertility beats Dynatronics on 7 of the 13 factors compared between the two stocks. Get INVO Fertility News Delivered to You Automatically Sign up to receive the latest news and ratings for IVF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IVF vs. The Competition Export to ExcelMetricINVO FertilitySurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.24M$78.71M$5.62B$9.84BDividend YieldN/AN/A4.61%4.07%P/E Ratio-0.0210.2130.2925.74Price / Sales0.1993.58463.41115.83Price / CashN/A18.4138.2159.48Price / Book-0.027.438.826.15Net Income-$9.10M-$26.39M$3.25B$265.06M7 Day Performance-2.78%1.12%3.71%2.60%1 Month Performance-26.06%6.19%5.85%2.83%1 Year Performance-94.28%47.18%29.92%25.58% INVO Fertility Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IVFINVO FertilityN/A$1.75+1.7%N/A-94.6%$1.24M$6.53M-0.0225News CoverageEarnings ReportDYNTDynatronicsN/A$0.08-0.5%N/A-47.1%$1.06M$33.60M-0.10200Gap UpTTOOT2 BiosystemsN/A$0.02-80.6%N/A-99.5%$326K$7.68M0.00180Short Interest ↓Gap DownIONMAssureN/A$0.05flatN/AN/A$150K$149K0.00130GMVDFG Medical InnovationsN/A$0.00flatN/AN/A$26K$4.42M0.0072AFIBAcutus MedicalN/A$0.00flatN/A-98.2%$15K$7.16M0.00340NMRDNemaura Medical1.2101 of 5 starsN/AN/AN/A$4K$3.02K0.0040UTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160News CoverageMOTSMotus GI0.1359 of 5 stars$0.00flatN/AN/A$1K$319K0.0030BVSBioventus3.017 of 5 stars$6.14-2.8%$13.75+123.9%-8.3%$504.36M$567.70M-10.071,200Analyst RevisionHigh Trading VolumeCATXPerspective Therapeutics1.6841 of 5 stars$3.92+0.8%$12.56+220.3%-70.8%$290.97MN/A0.0070 Related Companies and Tools Related Companies Dynatronics Competitors T2 Biosystems Competitors Assure Competitors G Medical Innovations Competitors Acutus Medical Competitors Nemaura Medical Competitors Minerva Surgical Competitors Motus GI Competitors Bioventus Competitors Perspective Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IVF) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Fertility, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Fertility With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access